Leading pharmaceutical company in KSA
Leading Pharmaceutical Company in KSA
DEEF Pharmaceutical Industries started production in June 2007 with the vision of establishing a Saudi factory running by international standards. DEEF founders are results-oriented, aiming for sustainable growth and providing high quality pharmaceutical products in Saudi Arabia and the GCC countries.
quality & development
Research & Development
Our Quality Policy
DEEF Pharmaceutical Industries Co. is committed towards manufacturing and marketing of pharmaceutical products following an integrated quality system,meeting customer and regulatory requirements ensuring the quality, safety and efficacy of the product.
Striving for excellence through continuous upgrading of resources and facilities to meet the ever-changing demands with respect to technologies and GMP, aiming at continuous quality improvement and customer satisfaction, giving due consideration to protection of the environment. Providing training, safe working environment and striving for the better cause of community.
DEEF Pharmaceutical Industries Co. is committed to manufacture and market its products following integrated quality system meeting patient needs, cGMP standards and regulatory guidelines; ensuring the quality, safety and efficacy of the products.
Central to this strategy is the establishment and maintenance of a documented system of quality management, extending from the product development through supply chain, manufacturing, marketing, sales, and finally distribution to the customer.
DEEF Quality Management System is based on ICH Q10 model coupled with ICH Q8 (Pharmaceutical Development) and ICH Q9 (Risk Management). This gives us a comprehensive and effective pharmaceutical quality system.
Striving for excellence through continuous improvement is the way of life in DEEF
DEEF has truly integrated R&D dept. & R&D team have expertise in high quality generic formulation development with the innovative approaches & fostering technologies to address the unmet needs of medical community.
Our research strategy is driven by the most up-to-date scientific merit and our comprehensive approach is to ensure formulation development to pursue Quality Target Product Profile based on Process Analytical Techniques (PAT), Design of Experiments (DoE), Quality by Design (QBD) principles which leverage to develop robust, reproducible and regulatory compiled high quality generic pharmaceutical products across the various therapeutic segments.
Mission & vision
To provide the Saudi community and our international clients with highest quality and cost-effective pharmaceutical products that enables healthy well-being and a better life.
To be one of the top ranking branded-generic pharmaceutical companies in the Kingdom of Saudi Arabia with a solid presence in the MENA region. and eventually other attractive markets.